Freestone Capital Holdings’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$276K Sell
3,848
-198
-5% -$15.3K 0.01% 457
2025
Q4
$321K Sell
4,046
-170
-4% -$13.4K 0.01% 409
2025
Q3
$318K Buy
4,216
+213
+5% +$14.6K 0.01% 417
2025
Q2
$276K Sell
4,003
-380
-9% -$24.9K 0.01% 376
2025
Q1
$297K Sell
4,383
-703
-14% -$42.1K 0.01% 356
2024
Q4
$228K Sell
5,086
-1,781
-26% -$99.9K 0.01% 399
2024
Q3
$432K Buy
6,867
+146
+2% +$8.52K 0.01% 313
2024
Q2
$397K Sell
6,721
-2,275
-25% -$142K 0.01% 336
2024
Q1
$718K Sell
8,996
-312
-3% -$23.8K 0.03% 259
2023
Q4
$735K Sell
9,308
-554
-6% -$39.4K 0.03% 231
2023
Q3
$689K Sell
9,862
-5,342
-35% -$379K 0.04% 213
2023
Q2
$1.05M Sell
15,204
-1,369
-8% -$97.4K 0.04% 182
2023
Q1
$1.23M Buy
16,573
+709
+4% +$59.5K 0.05% 173
2022
Q4
$1.48M Sell
15,864
-12,035
-43% -$1.16M 0.07% 160
2022
Q3
$2.66M Sell
27,899
-12,094
-30% -$1.2M 0.12% 118
2022
Q2
$3.71M Sell
39,993
-6,011
-13% -$587K 0.14% 100
2022
Q1
$4.66M Sell
46,004
-2,195
-5% -$231K 0.19% 115
2021
Q4
$4.97M Buy
48,199
+3,525
+8% +$326K 0.21% 101
2021
Q3
$3.79M Buy
44,674
+1,657
+4% +$139K 0.19% 124
2021
Q2
$3.59M Buy
43,017
+200
+0.5% +$16.4K 0.18% 133
2021
Q1
$3.22M Buy
42,817
+36,501
+578% +$2.66M 0.18% 135
2020
Q4
$431K Sell
6,316
-6,393
-50% -$416K 0.03% 257
2020
Q3
$742K Buy
12,709
+3,671
+41% +$228K 0.05% 200
2020
Q2
$26.5K Sell
9,038
-11,280
-56% -$710K 0.31% 16
2020
Q1
$24.9K Sell
20,318
-35,008
-63% -$2.34M 0.54% 15
2019
Q4
$33.8K Sell
55,326
-41,563
-43% -$2.92M 0.7% 14
2019
Q3
$6.11K Sell
96,889
-87,288
-47% -$5.17M 0.15% 58
2019
Q2
$10K Sell
184,177
-37,898
-17% -$2.04M 0.26% 26
2019
Q1
$12M Sell
222,075
-65,515
-23% -$4.04M 0.71% 36
2018
Q4
$18.8M Sell
287,590
-26,553
-8% -$1.98M 1.28% 15
2018
Q3
$24.7M Buy
314,143
+278,044
+770% +$19.9M 0.16% 17
2018
Q2
$2.32M Buy
36,099
+11,901
+49% +$784K 0.01% 155
2018
Q1
$1.51M Buy
+24,198
New +$1.74M 0.09% 175
2015
Q1
Sell
-17,224
Closed -$1.66M 185
2014
Q4
$1.66M Buy
17,224
+139
+0.8% +$12.2K 0.27% 48
2014
Q3
$1.36M Sell
17,085
-566
-3% -$44.6K 0.24% 63
2014
Q2
$1.33M Sell
17,651
-1,919
-10% -$145K 0.21% 83
2014
Q1
$1.47M Sell
19,570
-9,936
-34% -$702K 0.26% 61
2013
Q4
$2.11M Sell
29,506
-682
-2% -$43.8K 0.37% 43
2013
Q3
$1.71M Buy
30,188
+2,456
+9% +$146K 0.31% 58
2013
Q2
$1.59M Buy
+27,732
New +$1.61M 0.33% 47

Other funds holding CVS

Freestone Capital Holdings's CVS Position: Q1 2026 in Review

Freestone Capital Holdings reduced its CVS Health (CVS) stake by 4.9% in Q1 2026, selling an estimated $15.3K and leaving 3,848 shares worth $276K. The position accounts for 0.01% of the portfolio, ranked #457.

Freestone Capital Holdings first reported a position in CVS in Q2 2013 and has held it in 40 quarters since. The position peaked at $24.7M in Q3 2018. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Freestone Capital Holdings held 3,848 shares of CVS Health worth $276K as of Q1 2026.
  • Freestone Capital Holdings sold 198 CVS Health shares in Q1 2026, an estimated $15.3K.
  • CVS Health made up 0.01% of Freestone Capital Holdings's portfolio in Q1 2026, its #457 holding.
  • Freestone Capital Holdings first reported a position in CVS Health in Q2 2013 and has held it in 40 quarters since.
  • Freestone Capital Holdings's CVS Health position peaked at $24.7M in Q3 2018.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Freestone Capital Holdings's 13F filing for Q1 2026, filed 13 May 2026.